» Authors » Nao Takahashi

Nao Takahashi

Explore the profile of Nao Takahashi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 65
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nishiyama M, Koreki A, Isose S, Takeda T, Ishikawa A, Kokubun S, et al.
J Psychosom Res . 2024 Sep; 187:111915. PMID: 39270519
Objective: Although psychological distress is a prevalent issue among patients with amyotrophic lateral sclerosis (ALS) and can impact survival, the risk factors contributing to this distress remain insufficiently understood. Methods:...
2.
Sakai K, Niimi M, Momosaki R, Hoshino E, Yoneoka D, Nakayama E, et al.
Cochrane Database Syst Rev . 2024 Aug; 8:CD014852. PMID: 39145517
Background: Stroke patients often face disabilities that significantly interfere with their daily lives. Poor nutritional status is a common issue amongst these patients, and malnutrition can severely impact their functional...
3.
Omata J, Ueki Y, Takahashi Y, Tanaka R, Yokoyama Y, Takahashi T, et al.
Laryngoscope . 2024 May; 134(9):E30. PMID: 38757672
No abstract available.
4.
Wakasugi R, Sasaki T, Takano S, Kamada H, Yoshioka K, Tochigi K, et al.
Eur Arch Otorhinolaryngol . 2024 Jan; 281(6):2985-2991. PMID: 38219246
Purpose: Removal of the current calcium alginate packing materials to the middle meatus in endoscopic sinus surgery (ESS) is usually accompanied by discomfort or pain owing to the hard and...
5.
Ueki Y, Ohshima S, Yokoyama Y, Takahashi T, Shodo R, Yamazaki K, et al.
Int J Clin Oncol . 2023 Oct; 29(1):20-26. PMID: 37843751
Background: The optimal chemotherapy regimen in concurrent chemoradiotherapy (CCRT) for cisplatin-ineligible head and neck squamous cell carcinoma (HNSCC) has not been established. We aimed to evaluate the feasibility, efficacy, and...
6.
Omata J, Ueki Y, Takahashi Y, Tanaka R, Yokoyama Y, Takahashi T, et al.
Laryngoscope . 2023 Sep; 134(4):1679-1686. PMID: 37698411
Objective: Recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) treatment has changed dramatically with the introduction of immune checkpoint inhibitors (ICIs). However, there are few reports of treatment outcomes on...
7.
Takahashi N, Terauchi Y, Tanaka T, Yoshimi A, Yabu H, Abe K
Biosci Biotechnol Biochem . 2023 May; 87(8):857-864. PMID: 37253619
Hydrophobins are small amphiphilic proteins that are conserved in filamentous fungi. They localized on the conidial surface to make it hydrophobic, which contributes to conidial dispersal in the air, and...
8.
Otaki K, Takahashi T, Tanaka R, Saijo K, Omata J, Yokoyama Y, et al.
Front Surg . 2023 Jan; 9:1035349. PMID: 36589621
Objective: The global standard for chemoradiation therapy (CCRT) for head and neck squamous cell carcinoma is cisplatin 100 mg/m administered once every three weeks, although cisplatin 80 mg/m is also...
9.
Shoji M, Kurokawa H, Takahashi N, Sugimura R, Takamizawa T, Iwase K, et al.
Dent Mater J . 2022 Mar; 41(4):560-566. PMID: 35321976
The purpose of this study was to investigate the protective effect of a glass ionomer cement (GIC) consisting of fluoro-zinc-silicate glass on the demineralization of bovine dentin using the ultrasonic...
10.
Takahashi N, Kurokawa H, Wakamatsu K, Hirokane E, Takamizawa T, Miyazaki M, et al.
Dent Mater J . 2021 Sep; 41(1):134-141. PMID: 34556595
This study investigated the bonding performance of two different types of resin cements to computer-aided design/computer-aided manufacturing (CAD/CAM) composite blocks based on the shear bond strength (SBS) test. A silane-containing...